1. Introduction {#sec1-materials-09-00149}
===============

In recent years, controlled drug delivery systems for modern drug therapy have been attracting increasing attention because they exhibit low toxicity, a wide therapeutic window, and ideal drug efficacy as compared to conventional drug delivery systems \[[@B1-materials-09-00149],[@B2-materials-09-00149]\]. The multifunctional nanocomposites combine with magnetic and luminescent properties in one entity, and they have attracted great attention in recent years owing to their potential application in the biotechnology and nanomedicine fields including magnetic resonance imaging (MRI), cell separation, drug delivery agents, cell separation, labeling, and optical probes \[[@B3-materials-09-00149],[@B4-materials-09-00149],[@B5-materials-09-00149]\]. In the choice of luminescent nanomaterials for labeling, targeting and imaging, lanthanide-doped nanomaterials possess many of advantages such as high fluorescence quantum yields, low toxicity, long lifetimes, and high stability in comparison to quantum dots and organic dyes \[[@B5-materials-09-00149],[@B6-materials-09-00149],[@B7-materials-09-00149],[@B8-materials-09-00149]\].

So far, there have been some reports of constructing multifunctional nanomaterials that were made up of Fe~3~O~4~ and lanthanide-doped nanomaterials. In these reports \[[@B8-materials-09-00149],[@B9-materials-09-00149],[@B10-materials-09-00149],[@B11-materials-09-00149],[@B12-materials-09-00149]\], if the lanthanide-doped nanomaterials are chosen as cores, their luminescent intensity may be suppressed to some extent due to the coating of the outer layers. Meanwhile, if the lanthanide-doped nanomaterials are in direct contact with Fe~3~O~4~, their luminescence may be decreased as the direct contact can cause fluorescence-quenching \[[@B13-materials-09-00149],[@B14-materials-09-00149],[@B15-materials-09-00149]\]. Therefore, a SiO~2~ mid-layer between Fe~3~O~4~ and lanthanide-doped nanomaterials is needed.

To the best of our knowledge, there are no previous reports on the combination of magnetic properties with gadolinium vanadate nanophosphors. The previous investigation results indicated that nanosized GdVO~4~:Ln^3+^ phosphors have a significant application in a high definition flat display panels and potential applications in biology \[[@B16-materials-09-00149],[@B17-materials-09-00149],[@B18-materials-09-00149],[@B19-materials-09-00149]\]. Compared with Ln^3+^-activated YVO~4~, GdVO~4~:Ln^3+^ exhibits highly efficient emitting phosphors, in which the energy transfers from the GdVO~4~ host to the incorporated Ln^3+^ ions through V^5+^--O^2−^ charge transfer (CT), yielding an efficient luminescence of Ln^3+^ activators.

Herein, we develop, for the first time, a novel and simple route to prepare Fe~3~O~4~\@SiO~2~\@GdVO~4~:Dy^3+^ core-shell microspheres with excellent magnetic and luminescence properties. The good aqueous colloidal stability, low toxicity and excellent self-heating efficacy make these novel magnetic, luminescent nanomaterials suitable for the hyperthermia treatment of cancer, and the luminescent entity helps us to identify the location of magnetic nanoparticles during *in vitro* cellular imaging \[[@B20-materials-09-00149],[@B21-materials-09-00149],[@B22-materials-09-00149],[@B23-materials-09-00149],[@B24-materials-09-00149]\].

2. Results and Discussion {#sec2-materials-09-00149}
=========================

[Figure 1](#materials-09-00149-f001){ref-type="fig"} depicts the X-ray diffraction (XRD) patterns of as-synthesized Fe~3~O~4~, Fe~3~O~4~\@SiO~2~ and Fe~3~O~4~\@SiO~2~\@GdVO~4~:Dy^3+^ nanoparticles. From [Figure 1](#materials-09-00149-f001){ref-type="fig"}, we can find that there are characteristic diffraction peaks of Fe~3~O~4~, with a face-centered-cubic structure in all curves according to JCPDS card No. 65-3107. Besides the corresponding peaks of Fe~3~O~4~, SiO~2~ (JCPDS card No. 29-0085) and GdVO~4~ (JCPDS card No.86-0996) can be detected in [Figure 1](#materials-09-00149-f001){ref-type="fig"}a--c, respectively. No peaks corresponding to impurities are detected, showing the adequate purity of the Fe~3~O~4~\@SiO~2~\@GdVO~4~:Dy^3+^ composites.

The morphology and size details of the composites were characterized by SEM (scanning electronic microscope) and TEM (transmission electron microscopy) images. SEM investigations, as displayed in [Figure 2](#materials-09-00149-f002){ref-type="fig"}a, reveal that the magnetic cores of Fe~3~O~4~ particles are of a rough appearance and have an average size of 290 (±20) nm. Once coated with one layer of silica, the composite microspheres are slightly larger in diameter and have a relatively smooth surface, with their size increased up to 320 (±30) nm, as shown in [Figure 2](#materials-09-00149-f002){ref-type="fig"}b. The average size of the core-shell nanocomposites finally increased up to 360 (±25) nm, as illustrated in [Figure 2](#materials-09-00149-f002){ref-type="fig"}c. The representative TEM images in [Figure 2](#materials-09-00149-f002){ref-type="fig"}e,f indicate that the nanocomposites exhibit a core-shell structure.

To estimate the magnetic sensitivity, the room temperature magnetization hysteresis loops of the as-prepared cores and core-shell nanocomposites were collected and displayed in [Figure 3](#materials-09-00149-f003){ref-type="fig"}. The magnetic hysteresis loops in [Figure 3](#materials-09-00149-f003){ref-type="fig"} indicate that they have saturation magnetizations of 83.9 emu/g (Fe~3~O~4~), 27.8 emu/g (Fe~3~O~4~\@SiO~2~) and 20.4 emu/g (Fe~3~O~4~\@SiO~2~\@GdVO~4~:Dy^3+^) as well as negligible coercivity at room temperature, implying characteristics of their strong magnetism. The reduction of saturation magnetization could be attributed to the nonmagnetic shells (SiO~2~ and GdVO~4~:Dy^3+^). Our study revealed that, though the magnetism of the core-shell nanocomposites is less than that of the bare magnetic cores, it still possesses enough magnetic response for biomedical applications such as MRI, which is effectively magnetic separation.

The photoluminescence spectra of Fe~3~O~4~\@SiO~2~\@GdVO~4~:Dy^3+^ are shown in [Figure 4](#materials-09-00149-f004){ref-type="fig"}. In the excitation spectra ([Figure 4](#materials-09-00149-f004){ref-type="fig"}A), the excitation band at 300--350 nm monitored with a 571 nm emission of ^4^F~9/2~--^6^H1~3/2~ electronic transition of Dy^3+^ can be attributed to a charge transfer through the V--O bond overlay of the Dy--O charge transfer band. The emission spectra of GdVO~4~:Dy^3+^ are shown in [Figure 4](#materials-09-00149-f004){ref-type="fig"}B. The main emission peaks at 481 nm and 571 nm are results of the ^4^F~9/2~--^6^H~15/2~ transition and ^4^F~9/2~--^6^H~13/2~ transition of Dy^3+^ ions. Moreover, [Figure 4](#materials-09-00149-f004){ref-type="fig"} shows the excitation spectra and emission spectra of Fe~3~O~4~\@SiO~2~\@GdVO~4~:Dy^3+^ composites with different doped concentrations of Dy^3+^ ions. It is shown that the optimum doped concentration of Dy^3+^ ions in the Fe~3~O~4~\@SiO~2~\@GdVO~4~:Dy^3+^ composites is 1 mol %.

To investigate the porous structure of the Fe~3~O~4~\@SiO~2~\@GdVO~4~:Dy^3+^ nanocomposites, the N~2~ adsorption-desorption isotherms were investigated and are shown in [Figure 5](#materials-09-00149-f005){ref-type="fig"}. This isotherm profile can be categorized as type IV, with a small hysteresis loop observed at a relative pressure of 0.05--1.0, indicating the mesoporous features. The inset in [Figure 5](#materials-09-00149-f005){ref-type="fig"} is the pore size distribution. As calculated by the Brunauer-Emmett-Teller (BET) method, Fe~3~O~4~\@SiO~2~\@GdVO~4~:Dy^3+^ nanocomposites' core-shell structure gives rise to a BET area of 30.21 m^2^·g^−1^, with a relatively high pore volume of 0.212 cm^3^·g^−1^, and the average pore diameter is 17.46 nm. The BET indicated the potential of such nanostructures for drug delivery applications.

To evaluate the cytotoxicity of the Fe~3~O~4~\@SiO~2~\@GdVO~4~:Dy^3+^ nanoparticles, *in vitro* cytotoxicity tests against HeLa cells were carried out. From the 3-\[4,5-dimethylthiazol-2-y1\]-2,5-diphenyltetrazolium bromide (MTT) viability histogram, shown in [Figure 6](#materials-09-00149-f006){ref-type="fig"}, we can find that the Fe~3~O~4~\@SiO~2~\@GdVO~4~:Dy^3+^ causes insignificant damage to the HeLa cells when the sample concentration increases to 200 μg·mL^−1^ for 24 h, and the cell viability remains at 90.38% even at the highest concentration, which indicates that Fe~3~O~4~\@SiO~2~\@GdVO~4~:Dy^3+^ nanoparticles are biocompatible.

3. Materials and Methods {#sec3-materials-09-00149}
========================

3.1. Materials {#sec3dot1-materials-09-00149}
--------------

All reagents are of analytical reagent grade and used without further purification. Gd~2~O~3~ (99.9%) and Eu~2~O~3~ (99.9%) were purchased from Jinan Camolai Trading Company, Ferrous chloride hexahydrate (FeCl~3~·6H~2~O) (99%), tetraethyl orthosilicate (TEOS, 99.0%), sodium acetate (NaAc), Citrate acid monohydrate were purchased from Beijing Chemicals Corporation. Nitric acid, ethanol, ethylene glycol (EG), and ammonia aqueous (25%) were purchased from Tianjin Chemicals Corporation. Deionized water obtained from the Milli-Q system (Millipore, Bedford, MA, USA) was used in all experiments. The magnetic Fe~3~O~4~ nanoparticles were prepared using a modified solvothermal reaction.

3.2. Synthesis of Fe~3~O~4~ {#sec3dot2-materials-09-00149}
---------------------------

The magnetic Fe~3~O~4~ nanoparticles were prepared according to a previously reported synthetic process \[[@B19-materials-09-00149]\]. Typically, FeCl~3~·6H~2~O (1.3495 g) and NaAc (7.1926 g) were dissolved in EG solution (40 mL). Then PEG-10000 (1.0015 g) was added with vigorous stirring and the mixture was stirred for 30 min to form a homogeneous russet solution. The obtained solution was transferred to a Teflon-lined stainless-steel autoclave (50 mL capacity) and heated at 200 °C for 10 h. Subsequent cooling to room temperature yielded black magnetite particles, which were washed with ethanol and deionized water three times, respectively, and dried at 60 °C for 12 h.

3.3. Synthesis of Fe~3~O~4~\@SiO~2~ {#sec3dot3-materials-09-00149}
-----------------------------------

Fe~3~O~4~\@SiO~2~ nanoparticles were prepared according to the modified by the Stöber method. In brief, 1.0 g of Fe~3~O~4~ nanoparticles were homogeneously dispersed in a mixture of 160 mL of ethanol, 40 mL of deionized water, and 3.0 mL of 28 wt % concentrated ammonia aqueous solution, followed by the addition of 3.0 mL of tetraethyl orthosilicate (TEOS). After vigorous stirring at 40 °C for 6 h, the obtained Fe~3~O~4~\@SiO~2~ microspheres were separated with a magnet and washed repeatedly with ethanol and deionized water to remove nonmagnetic by products.

3.4. Synthesis of Fe~3~O~4~\@SiO~2~\@GdVO~4~:Dy^3+^ Nanoparticles {#sec3dot4-materials-09-00149}
-----------------------------------------------------------------

Functionalization of GdVO~4~:Dy^3+^ on the template Fe~3~O~4~\@SiO~2~ was achieved according to the reported process with a doping concentration of Dy^3+^ of 0.5--4 mol % to Dy^3+^ in GdVO~4~:Dy^3+^. The typical procedure for synthesis is described as follows: stoichiometric amounts of Gd~2~O~3~, Dy~2~O~3~ and citric acid were dissolved in dilute nitric acid with heating followed by the addition of NH~4~VO~3~ in distilled water. Then PEG-10000 was added with a concentration of 0.05 g·mL^−1^. After stirring for 0.5 h, a homogenous sol was formed. Then the desired amount of Fe~3~O~4~\@SiO~2~ nanoparticles was added into the gel, after further stirring for another 3 h, the resulting material was dried at 120 °C for 12 h to obtain the precursors. Then the precursors were calcined at 700 °C for another 4 h. The obtained nanoparticles were denoted as Fe~3~O~4~\@SiO~2~\@GdVO~4~:Dy^3+^ ([Scheme 1](#materials-09-00149-f007){ref-type="scheme"}).

3.5. Cytotoxicity Study of Fe~3~O~4~\@SiO~2~\@GdVO~4~:Dy^3+^ Nanoparticle {#sec3dot5-materials-09-00149}
-------------------------------------------------------------------------

Cell viabilities of Fe~3~O~4~\@SiO~2~\@GdVO~4~:Dy^3+^ nanoparticles at different concentrations were tested by MTT assay on HeLa (human cervical cancer cells). In the experiment, the corresponding untreated cells were used as control. First, the HeLa cells were pre-incubated in a 96-well plate (about 3000 cells per well) for 24 h. Second, 2 mg of the Fe~3~O~4~\@SiO~2~\@GdVO~4~:Dy^3+^ nanoparticles were added into 10 mL of 0.01 M phosphate buffered saline (PBS, pH = 7.4) to form a stable orange solution. Third, the above solution at concentrations of 6.25, 12.5, 25, 50, 100 or 200 μg·mL^−1^ was added to the cells. Six parallel-group experiments were simultaneously conducted for each concentration. After 24 h, the viability of HeLa cells was examined by a MTT assay.

3.6. Characterization {#sec3dot6-materials-09-00149}
---------------------

The purities of all the nanoparticles were checked by X-ray diffraction (XRD) measurements at room temperature using Cu Kα radiation (Kα = 1.54059 Å). The morphology and microscope structure of all the nanocomposites were characterized by a scanning electronic microscope (SEM, NoVa™ Nano SEM 430, FEI Co., Ltd., Hillsboro, OR, USA) and transmission electron microscopy (TEM, JEOL JEM-2010F, JEOL Co., Ltd., Tokyo, Japan). The room temperature magnetic hysteresis (M-H) loops were measured using a superconducting quantum interference device vibrating sample magnetometry (SQUID-VSM, Quantum Design Co., Ltd., San Diego, CA, USA). Luminescence spectra were recorded on a FluoroMax-4 spectrophotometer (HORIBA Jobin Yvon Co., Ltd., Paris, France). The specific surface area was determined by the Brunauer-Emmett-Teller (BET) method. The HeLa cells were assayed for viability by using a microplate reader (Bio-Rad 680, Bio-Rad Co., Ltd., Hercules, CA, USA).

4. Conclusions {#sec4-materials-09-00149}
==============

In summary, we report a novel magnetic/luminescence multifunctional nanocomposite, Fe~3~O~4~\@SiO~2~\@GdVO~4~:Dy^3+^, with a core-shell structure from a combination of hydrothermal reaction and the sol-gel process. The as-prepared nanocomposites, combining the merits of the good magnetic response of the assembled Fe~3~O~4~\@SiO~2~ microspheres and the fluorescence property of GdVO~4~:Dy^3+^, displayed high surface area and biocompatibility. Therefore, our study may provide new insight and useful information for the design of diverse, functional nanocomposites as drug carriers.
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![X-ray diffraction (XRD) patterns of pure Fe~3~O~4~ (**a**); Fe~3~O~4~\@SiO~2~ (**b**) and Fe~3~O~4~\@SiO~2~\@GdVO~4~:Dy^3+^ (**c**). The diffraction peaks that are indexed in 1c correspond to GdVO~4~.](materials-09-00149-g001){#materials-09-00149-f001}

![Scanning electronic microscope (SEM) images of Fe~3~O~4~ (**a**); Fe~3~O~4~\@SiO~2~ (**b**); Fe~3~O~4~\@SiO~2~\@GdVO~4~:Dy^3+^ (**c**); and transmission electron microscopy (TEM) images of Fe~3~O~4~ (**d**); Fe~3~O~4~\@SiO~2~ (**e**); Fe~3~O~4~\@SiO~2~\@GdVO~4~:Dy^3+^ (**f**).](materials-09-00149-g002){#materials-09-00149-f002}

![The magnetic hysteresis loops of pure Fe~3~O~4~ (**a**); Fe~3~O~4~\@SiO~2~ (**b**); and Fe~3~O~4~\@SiO~2~\@GdVO~4~:Dy^3+^ (**c**).](materials-09-00149-g003){#materials-09-00149-f003}

![Excitation spectra (**A**) and emission spectra (**B**) of Fe~3~O~4~\@SiO~2~\@GdVO~4~:Dy^3+^ with different doped concentrations of Dy^3+^ (a: 0.5%, b: 1%, c: 2%, d: 3% and e: 4%).](materials-09-00149-g004){#materials-09-00149-f004}

![The N~2~ adsorption/desorption isotherms and pore size distribution (inset) of Fe~3~O~4~\@SiO~2~\@GdVO~4~:Dy^3+^.](materials-09-00149-g005){#materials-09-00149-f005}

![The viability histograms of HeLa cells incubated with different concentrations of Fe~3~O~4~\@SiO~2~\@GdVO~4~:Dy^3+^ nanoparticles for 24 h measured by a 3-(4,5-dimethylthiazol-2-y1)-2,5-diphenyltetrazolium bromide (MTT) assay.](materials-09-00149-g006){#materials-09-00149-f006}

![Illustration for the synthesis process of the spherical Fe~3~O~4~\@SiO~2~\@GdVO~4~:Dy^3+^ nanocomposite.](materials-09-00149-g007){#materials-09-00149-f007}
